| Nicholas F Taflin, MD | |
|
30 N 1900 E Rm 5c402, Salt Lake City, UT 84132-0002 | |
| (801) 581-2121 | |
| Not Available |
| Full Name | Nicholas F Taflin |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 30 N 1900 E Rm 5c402, Salt Lake City, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205464948 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 13284725-1205 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas F Taflin, MD 30 N 1900 E Rm 5c402, Salt Lake City, UT 84132-0002 Ph: (801) 581-2121 | Nicholas F Taflin, MD 30 N 1900 E Rm 5c402, Salt Lake City, UT 84132-0002 Ph: (801) 581-2121 |
News Archive
In a study to be presented Friday, Jan. 27, in the oral plenary session at 8 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, researchers with University of Utah Health Sciences Center, Intermountain Healthcare and the Huntsman Cancer Institute (all in Salt Lake City, Utah), will present the study, Long-term mortality risk and life expectancy following recurrent hypertensive disease of pregnancy.
Eating about one serving per day of green, leafy vegetables may be linked to a slower rate of brain aging, according to a study published in the December 20, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
The Cancer Research Institute, a nonprofit organization dedicated to fueling the discovery and development of immunotherapies for all forms of cancer, announced that it has committed more than $29.3 million in new funds to accelerate cancer immunology research and cancer immunotherapy clinical development in the United States, Australia, Canada, France, Sweden, Switzerland, and The Netherlands.
Pacira Pharmaceuticals, Inc. today announced the commercial launch of EXPAREL (bupivacaine liposome injectable suspension) in the United States. Starting today, EXPAREL will begin shipping to hospital and ambulatory care customers through their normal wholesaler and distributor channels.
A new type of treatment for osteoarthritis, currently in canine clinical trials, shows promise for eventual use in humans.
› Verified 6 days ago
Dr. Mehmet Akkaya, M.D Hematology & Oncology Medicare: Medicare Enrolled Practice Location: University Of Utah Hospital Cardiology, 3o N,1900 E, Rm:4a100, Salt Lake City, UT 84132 Phone: 801-505-1689 | |
Dr. Willard Dere, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 500 Foothill Blvd, Salt Lake City, UT 84148 Phone: 801-582-1565 | |
Megan Meier, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Joel Money, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Mchale O. Anderson, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4a100, Salt Lake City, UT 84132 Phone: 801-587-2451 | |
Siddharth K. Iyengar, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4c116, Salt Lake City, UT 84132 Phone: 801-581-7606 | |
Taryn A. Young, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 5121 S Cottonwood St, Salt Lake City, UT 84107 Phone: 801-507-4384 Fax: 801-507-4398 |